The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels.
D000293:Adolescent; D000328:Adult; D000799:Angioedema / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D003174:Complement C1 Inactivator Proteins; D003181:Complement C4 / Q000032:analysis*; D003169:Complement Inactivator Proteins; D003165:Complement System Proteins / Q000032:analysis*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005474:Fluoxymesterone / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D010110:Oxymetholone / Q000008:administration & dosage; D012008:Recurrence; D045165:Testosterone Congeners / Q000008:administration & dosage*
D003174:Complement C1 Inactivator Proteins; D003181:Complement C4; D003169:Complement Inactivator Proteins; D045165:Testosterone Congeners; D003165:Complement System Proteins; D005474:Fluoxymesterone; D010110:Oxymetholone